Memorial Sloan Kettering will provide the startup with anonymized clinical data, which Cota will organize through its Cota Nodal Address system. The Cota Nodal Address categorizes clinical and genomic data based on demographics, diseases and intended therapies of similar patients.
The data-sharing effort will help Memorial Sloan Kettering clinicians personalize patient care and advance oncology research, while also expanding Cota’s evidence database.
“This organized and analyzed data will help our physicians practice more efficiently, optimizing the care a patient receives based on a variety of characteristics and ultimately can improve outcomes for all cancer patients as this knowledge is shared,” said Paul Sabbatini, MD, deputy physician-in-chief for clinical research at Memorial Sloan Kettering.
More articles on health IT:
VA considers social, behavioral survey of 10k veterans to predict admissions
Harvard, UChicago among collaborators on NIH data commons project
Mount Sinai researchers develop model to predict patient responses to immunotherapy
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
